SANA

Sana Biotechnology (SANA)

About Sana Biotechnology (SANA)

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Details

Daily high
$2.41
Daily low
$2.20
Price at open
$2.29
52 Week High
$10.50
52 Week Low
$1.52
Market cap
504.6M
Dividend yield
0.00%
Volume
3.2M
Avg. volume
3.2M
P/E ratio
-1.93

Sana Biotechnology News

Details

Daily high
$2.41
Daily low
$2.20
Price at open
$2.29
52 Week High
$10.50
52 Week Low
$1.52
Market cap
504.6M
Dividend yield
0.00%
Volume
3.2M
Avg. volume
3.2M
P/E ratio
-1.93